CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Monday reported a loss of $29.3 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 39 cents per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
The biopharmaceutical company posted revenue of $7.9 million in the period.
Epizyme shares have increased 96% since the beginning of the year. The stock has fallen 12% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EPZM at https://www.zacks.com/ap/EPZM